1rarebird
06-27-2012, 04:54 AM
These sessions require per-registration but are well worth the effort to hear experts discuss the latest science in breast cancer research---bird
Role of P13K/mTOR pathway and its inhibitors in ER+ breast cancer: a new paradigm? CME accredited
e-grandround GR202 - 28 June 2012 - 18:15-19:00 CET
Expert: Fabrice André, Institut de Cancérologie Gustave Roussy, Villejuif, France
Discussant: Nadia Harbeck, Breast Centre, University of Munich, Munich, Germany
http://www.e-eso.net/egrandround.do?methodcall=details&id=235
Role of P13K/mTOR pathway and its inhibitors in ER+ breast cancer: a new paradigm? CME accredited
e-grandround GR202 - 28 June 2012 - 18:15-19:00 CET
Expert: Fabrice André, Institut de Cancérologie Gustave Roussy, Villejuif, France
Discussant: Nadia Harbeck, Breast Centre, University of Munich, Munich, Germany
http://www.e-eso.net/egrandround.do?methodcall=details&id=235